Photodynamic therapy of arteries. A novel approach for treatment of experimental intimal hyperplasia.

BACKGROUND Photodynamic therapy (PDT) uses light activation of otherwise nontoxic dyes for the production of reactive oxygen species that cause cell injury and death. METHODS AND RESULTS The inhibition of intimal hyperplasia (IH) by PDT was studied in the balloon injury model of the rat carotid artery. Chloroaluminum-sulfonated phthalocyanine (CASPc) was the drug chosen for PDT because it does not produce skin photosensitivity and has a high absorption peak of light at 675 nm, a wavelength with good tissue penetration. A pilot study indicated that CASPc administration with laser radiant exposure of 100 J/cm2 resulted in a homogeneous, circumferential effect on the whole artery. Male Sprague-Dawley rats received the balloon catheter injury to the left common carotid artery (day 0) and were equally divided into two groups. Nine rats received either CASPc (5 mg/kg i.v., n = 6) or saline (n = 3) at day 2, before IH was present, and nine rats received CASPc or saline in the same manner on day 7, when IH was already present. Twenty minutes after drug injection, the distal left common carotid artery was irradiated under saline with 675-nm laser light at 100 mW/cm2 for 10(3) seconds (100 J/cm2). At this low laser irradiance, there are no thermal effects, but photoactivation of CASPc occurs. The rats were killed at day 14 after balloon injury when IH reaches a maximum. The arteries were harvested after perfusion-fixation for light microscopy, histological and computerized morphometric evaluation, and transmission electron microscopy (TEM) analysis. The cross-sectional areas of the neointima were measured in the PDT-treated arteries and in the laser-only control arteries. There was a significant mean +/- SD decrease of IH in the PDT-irradiated segments of the arteries (0.06 +/- 0.05 mm2) versus the laser-only control ones (0.17 +/- 0.07 mm2) (t test, p less than 0.001), with no statistical difference between the day 2 and day 7 treated rats. Lack of IH was correlated in 90% of cases with histological absence of medial smooth muscle cells or inflammatory cells, but no other structural injury was identified. TEM analysis showed early evidence of PDT-mediated cytotoxic effects at 4 hours and the absence of collagen or elastic tissue structural alterations. CONCLUSIONS These data demonstrated that PDT can effectively inhibit the IH response when it is used before or during induction of cellular proliferation in this acute model. Although the long-term implications of PDT in arteries need to be defined, this technique may offer a new method for understanding and treating IH.

[1]  R. Dilley,et al.  A review of the histologic changes in vein-to-artery grafts, with particular reference to intimal hyperplasia. , 1988, Archives of surgery.

[2]  J. Douglas,et al.  Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study. , 1984, Circulation.

[3]  K. Karsch,et al.  Morphological Changes and Smooth Muscle Cell Proliferation After Experimental Excimer Laser Treatment , 1991, Circulation.

[4]  H. Baumgartner,et al.  Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. , 1989, Science.

[5]  Kevin M. Smith,et al.  SKIN PHOTOSENSITIVITY AND PHOTODESTRUCTION OF SEVERAL POTENTIAL PHOTODYNAMIC SENSITIZERS , 1989, Photochemistry and photobiology.

[6]  A. Clowes,et al.  Suppression by heparin of smooth muscle cell proliferation in injured arteries , 1977, Nature.

[7]  L Schwartz,et al.  Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. , 1988, The New England journal of medicine.

[8]  W S Grundfest,et al.  Effects of hematoporphyrin derivative and photodynamic therapy on atherosclerotic rabbits. , 1985, The American journal of cardiology.

[9]  P. Dartsch,et al.  Responses of cultured smooth muscle cells from human nonatherosclerotic arteries and primary stenosing lesions after photoradiation: implications for photodynamic therapy of vascular stenoses. , 1990, Journal of the American College of Cardiology.

[10]  J. Marshall,et al.  PHOTODYNAMIC THERAPY OF A MURINE TUMOR FOLLOWING SENSITISATION WITH CHLORO ALUMINUM SULFONATED PHTHALOCYANINE , 1987, Photochemistry and photobiology.

[11]  C. Jackson,et al.  Inhibitory effect of calcium antagonists on balloon catheter-induced arterial smooth muscle cell proliferation and lesion size. , 1988, Atherosclerosis.

[12]  I. Pastan,et al.  Cytotoxic Effects of a Recombinant Chimeric Toxin on Rapidly Proliferating Vascular Smooth Muscle Cells , 1991, Circulation.

[13]  T J Dougherty,et al.  PHOTOSENSITIZERS: THERAPY AND DETECTION OF MALIGNANT TUMORS , 1987, Photochemistry and photobiology.

[14]  F. Schoen,et al.  Vascular graft intimal fibrous hyperplasia: prospects for pharmacological inhibition. , 1991, Journal of vascular surgery.

[15]  Thanassis Papaioannou,et al.  Detection of atheroma using Photofrin IIr and laser-induced fluorescence spectroscopy , 1991, Photonics West - Lasers and Applications in Science and Engineering.

[16]  A. Imparato,et al.  Intimal and neointimal fibrous proliferation causing failure of arterial reconstructions. , 1972, Surgery.

[17]  M. Reidy,et al.  Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[18]  F. Figge,et al.  Cancer Detection and Therapy. Affinity of Neoplastic, Embryonic, and Traumatized Tissues for Porphyrins and Metalloporphyrins.∗ , 1948, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[19]  S Paulin,et al.  Fluorescence of experimental atheromatous plaques with hematoporphyrin derivative. , 1983, The Journal of clinical investigation.

[20]  R Linsker,et al.  Laser-induced fluorescence detection of atherosclerotic plaque with hematoporphyrin derivative used as an exogenous probe. , 1988, Journal of vascular surgery.

[21]  M. Reidy,et al.  Mechanisms of stenosis after arterial injury. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[22]  J. Parrish,et al.  New concepts in therapeutic photomedicine: photochemistry, optical targeting and the therapeutic window. , 1981, The Journal of investigative dermatology.

[23]  R. Rosenberg,et al.  Heparin‐like molecules regulate the number of epidermal growth factor receptors on vascular smooth muscle cells , 1988, Journal of cellular physiology.

[24]  C J Gomer,et al.  Differential cell photosensitivity following porphyrin photodynamic therapy. , 1988, Cancer research.

[25]  M. Brown,et al.  Targeted killing of cultured cells by receptor-dependent photosensitization. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M K Klein,et al.  Photodynamic therapy of spontaneous cancers in felines, canines, and snakes with chloro-aluminum sulfonated phthalocyanine. , 1991, Journal of the National Cancer Institute.

[27]  M. Karnovsky,et al.  Inhibition of Rat Arterial Smooth Muscle Cell Proliferation by Heparin: In Vivo Studies with Anticoagulant and Nonanticoagulant Heparin , 1980, Circulation research.

[28]  T. Hasan,et al.  Photoimmunotherapy of human ovarian carcinoma cells ex vivo. , 1991, Cancer research.

[29]  T Hasan,et al.  Photosensitized destruction of human bladder carcinoma cells treated with chlorin e6-conjugated microspheres. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Schwartz,et al.  Replication of smooth muscle cells in vascular disease. , 1986, Circulation research.

[31]  S. Schwartz,et al.  Significance of Quiescent Smooth Muscle Migration in the Injured Rat Carotid Artery , 1985, Circulation research.

[32]  M W Berns,et al.  In vitro photosensitization I. Cellular uptake and subcellular localization of mono‐L‐aspartyl chlorin e6, chloro‐aluminum sulfonated phthalocyanine, and photofrin II , 1989, Lasers in surgery and medicine.

[33]  V. Fuster,et al.  Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. , 1990, Journal of the American College of Cardiology.

[34]  I Rosenthal,et al.  PHTHALOCYANINES AS PHOTODYNAMIC SENSITIZERS * , 1991, Photochemistry and photobiology.

[35]  Karnovsky Mj,et al.  Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening. , 1975 .

[36]  D. Kessel,et al.  PORPHYRIN ACCUMULATION BY ATHEROMATOUS PLAQUES OF THE AORTA , 1984, Photochemistry and photobiology.

[37]  J. Spears,et al.  Uptake of hematoporphyrin derivative by atheromatous plaques: studies in human in vitro and rabbit in vivo. , 1986, Journal of the American College of Cardiology.

[38]  R. Ross,et al.  The biology of platelet-derived growth factor , 1986, Cell.

[39]  P. D. Cahill,et al.  Inhibition of vein graft intimal thickening by eicosapentanoic acid: reduced thromboxane production without change in lipoprotein levels or low-density lipoprotein receptor density. , 1988, Journal of vascular surgery.

[40]  K. Berg,et al.  EVALUATION OF SULFONATED ALUMINUM PHTHALOCYANINES FOR USE IN PHOTOCHEMOTHERAPY. A STUDY ON THE RELATIVE EFFICIENCIES OF PHOTOINACTIVATION , 1989, Photochemistry and photobiology.